No disclosed counterparties: BCO, CHRW.
| Stage | BCO | % of rev | CHRW | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.4B | 100.00% | $5.4B | 100.00% | CHRW ×3.85 |
| Gross profit | $366M | 26.29% | $448M | 8.36% | BCO +17.9pp |
| Operating income | $133M | 9.57% | $272M | 5.07% | BCO +4.5pp |
| Pre-tax income | $68M | 4.88% | $250M | 4.67% | BCO +0.2pp |
| Net income | $47M | 3.40% | $198M | 3.70% | CHRW +0.3pp |
| Stage | BCO | CHRW | Gap · A − B |
|---|---|---|---|
| Revenue | $1.4B100.00% | $5.4B100.00% | CHRW ×3.85 |
| Gross profit | 26.29%$366M | 8.36%$448M | BCO +17.9pp |
| Operating income | 9.57%$133M | 5.07%$272M | BCO +4.5pp |
| Pre-tax income | 4.88%$68M | 4.67%$250M | BCO +0.2pp |
| Net income |
| 3.40%$47M |
| 3.70%$198M |
| CHRW +0.3pp |